Cargando…
Type I macrophage activator photosensitizer against hypoxic tumors
Photodynamic immunotherapy has emerged as a promising strategy to treat cancer. However, the hypoxic nature of most solid tumors and notoriously immunosuppressive tumor microenvironment could greatly compromise the efficacy of photodynamic immunotherapy. To address this challenge, we rationally synt...
Autores principales: | Yang, Guang, Lu, Song-Bo, Li, Chong, Chen, Feng, Ni, Jen-Shyang, Zha, Menglei, Li, Yaxi, Gao, Ji, Kang, Tianyi, Liu, Chao, Li, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597846/ https://www.ncbi.nlm.nih.gov/pubmed/34820093 http://dx.doi.org/10.1039/d1sc04124j |
Ejemplares similares
-
Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy
por: Roque, John A., et al.
Publicado: (2020) -
A near-infrared light-activatable Ru(ii)-coumarin photosensitizer active under hypoxic conditions
por: Ortega-Forte, Enrique, et al.
Publicado: (2023) -
Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours
por: Wang, Youchao, et al.
Publicado: (2023) -
Acene enlargement for absorption red-shifting and photosensitization enhancement of photosensitizers with aggregation-induced emission
por: Wang, Qiang, et al.
Publicado: (2022) -
Synthesis and properties of novel type I photosensitizer polycyclic amide
por: Wang, Kui, et al.
Publicado: (2023)